DIFFUSE MALIGNANT PLEURAL MESOTHELIOMA - THERAPEUTIC ATTEMPTS

被引：3
|
作者：
CALAVREZOS, A
PAUSCH, C
HAIN, E
机构：
来源：
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 1982年 / 107卷 / 23期
关键词：
D O I：
10.1055/s-2008-1070045
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：906 / 908
页数：3
相关论文
共 50 条
  • [21] Expression of plakophilin 3 in diffuse malignant pleural mesothelioma
    Masic, Silvija
    Brcic, Luka
    Kruslin, Bozo
    Sepac, Ana
    Pigac, Biserka
    Stancic-Rokotov, Dinko
    Jakopovic, Marko
    Seiwerth, Sven
    HISTOLOGY AND HISTOPATHOLOGY, 2018, 33 (09) : 995 - 1004
  • [22] Histopathologic features predict survival in diffuse pleural malignant mesothelioma on pleural biopsies
    Cyril Habougit
    Béatrice Trombert-Paviot
    Georgia Karpathiou
    François Casteillo
    Sophie Bayle-Bleuez
    Pierre Fournel
    Jean-Michel Vergnon
    Olivier Tiffet
    Michel Péoc’h
    Fabien Forest
    Virchows Archiv, 2017, 470 : 639 - 646
  • [23] Histopathologic features predict survival in diffuse pleural malignant mesothelioma on pleural biopsies
    Habougit, Cyril
    Trombert-Paviot, Beatrice
    Karpathiou, Georgia
    Casteillo, Francois
    Bayle-Bleuez, Sophie
    Fournel, Pierre
    Vergnon, Jean-Michel
    Tiffet, Olivier
    Peoc'h, Michel
    Forest, Fabien
    VIRCHOWS ARCHIV, 2017, 470 (06) : 639 - 646
  • [24] Vinca alkaloids in the therapeutic management of malignant pleural mesothelioma
    Ceresoli, Giovanni Luca
    Zucali, Paolo Andrea
    CANCER TREATMENT REVIEWS, 2015, 41 (10) : 853 - 858
  • [25] Gli as a Novel Therapeutic Target in Malignant Pleural Mesothelioma
    Li, Hui
    Lui, Natalie
    Cheng, Tiffany
    Tseng, Hsin-Hui K.
    Yue, Dongsheng
    Giroux-Leprieur, Etienne
    Do, Hanh T.
    Sheng, Qing
    Jin, Joy Q.
    Luh, Thomas W.
    Jablons, David M.
    He, Biao
    PLOS ONE, 2013, 8 (03):
  • [26] An Update on Emerging Therapeutic Options for Malignant Pleural Mesothelioma
    Davis, Alexander
    Ke, Helen
    Kao, Steven
    Pavlakis, Nick
    LUNG CANCER-TARGETS AND THERAPY, 2022, 13 : 1 - 12
  • [27] The Investigation of Lipoxygenases as Therapeutic Targets in Malignant Pleural Mesothelioma
    Oguh-Olayinka, Lily
    Agarwal, Vijay
    Ranatunge, Dulani
    Campbell, Anne
    Laufer, Stefan
    Cawkwell, Lynn
    Lind, Michael J.
    PATHOLOGY & ONCOLOGY RESEARCH, 2020, 26 (02) : 985 - 995
  • [28] Ponatinib is a potential therapeutic approach for malignant pleural mesothelioma
    Yang, Yi-Wei
    Marrufo, Angelica
    Chase, Jillian
    Woodard, Gavitt A.
    Jablons, David M.
    Lemjabbar-Alaoui, Hassan
    EXPERIMENTAL LUNG RESEARCH, 2021, 47 (01) : 9 - 25
  • [29] Synchronous occurrence of pulmonary adenocarcinoma and pleural diffuse malignant mesothelioma
    Imenpour, H.
    Ivaldi, G. P.
    Brianti, A.
    Pastorino, G.
    Biggi, S.
    Auriati, L.
    Simonassi, C.
    PATHOLOGICA, 2013, 105 (06) : 353 - 356
  • [30] The therapeutic implications of the genomic analysis of malignant pleural mesothelioma
    Marjorie G. Zauderer
    Nature Communications, 12
12345